We noted that the ablation and inhibition of SMYD3 in SCLC cells partially delayed tumor growth (Fig. 1G), whereas additional CP treatment significantly halted tumor growth or caused some tumors to regress in size. Here, SMYD3 is linked to small cell lung carcinoma.